25 May 2013
Keywords: aventis, licenses, ketek, sankyo, fujisawa, franco-german, drugmaker
Article | 17 February 2003
Franco-German drugmaker Aventis has licensed Japanese rights to itsnew antibiotic Ketek (telithromycin) to Sankyo and Fujisawa Pharmaceutical. The drug has ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.